SCP
CO

Seizert Capital Partners’s Global Cord Blood Corporation CO Stock Holding History

Seizert Capital Partners’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-158,194
Closed -$910K – 246
2016
Q2 		$910K Sell
158,194
-29,104
-16% -$177K 0.03% 141
2016
Q1 		$1.14M Buy
187,298
+78,368
+72% +$468K 0.04% 147
2015
Q4 		$694K Buy
+108,930
New +$688K 0.02% 161

Other funds holding CO

Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PG
PEAK6 Group Chicago, Illinois $23.4B AUM 17.65% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

Seizert Capital Partners's CO Position: Q3 2016 in Review

Seizert Capital Partners sold out of Global Cord Blood Corporation (CO) in Q3 2016, closing a stake of 158,194 shares — an estimated $910K sold.

Seizert Capital Partners first reported a position in CO in Q4 2015 and held it in 3 quarters. The position peaked at $1.14M in Q1 2016. 30 funds tracked by Wall St. Rank hold CO as of Q3 2016.

  • Seizert Capital Partners reported no remaining Global Cord Blood Corporation position as of Q3 2016 after selling out during the quarter.
  • Seizert Capital Partners sold 158,194 Global Cord Blood Corporation shares in Q3 2016, an estimated $910K.
  • Seizert Capital Partners first reported a position in Global Cord Blood Corporation in Q4 2015 and held it in 3 quarters.
  • Seizert Capital Partners's Global Cord Blood Corporation position peaked at $1.14M in Q1 2016.
  • 30 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2016.

Based on Seizert Capital Partners's 13F filing for Q3 2016, filed 9 Nov 2016.